Literature DB >> 2446600

Low density lipoprotein (LDL) inhibits histamine release from human mast cells.

E S Schulman1, T J Quinn, T J Post, P O'Donnell, A Rodriguez, B Gonen.   

Abstract

We examined the effect of low density lipoprotein (LDL) on histamine release from purified human lung mast cells. LDL inhibited anti-IgE- induced histamine release in a dose-dependent manner, with 100 micrograms/ml LDL-protein inhibiting histamine release by 53 +/- 8% (mean +/- SEM); half-maximal inhibition occurred at 40-80 micrograms/ml. LDL also inhibited calcium ionophore A23187-induced histamine release in a dose-dependent manner, with 1 mg/ml of LDL inhibiting histamine release by 83 +/- 9%; half maximal inhibition occurred at 220-280 micrograms/ml. Inhibition by LDL was time-dependent: half-maximal inhibition of anti-IgE- induced histamine release by LDL occurred at 30-50 minutes of incubation. The inhibitory effect of LDL was independent of buffer calcium concentrations (0-5 mM) or temperature (0-37 degrees C). These data are consistent with a newly defined immunoregulatory role for LDL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446600     DOI: 10.1016/0006-291x(87)90912-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  The alpha-gal story: lessons learned from connecting the dots.

Authors:  John W Steinke; Thomas A E Platts-Mills; Scott P Commins
Journal:  J Allergy Clin Immunol       Date:  2015-03       Impact factor: 10.793

2.  Novel relationship of serum cholesterol with asthma and wheeze in the United States.

Authors:  Michael B Fessler; Mark W Massing; Brian Spruell; Renee Jaramillo; David W Draper; Jennifer H Madenspacher; Samuel J Arbes; Agustin Calatroni; Darryl C Zeldin
Journal:  J Allergy Clin Immunol       Date:  2009-10-03       Impact factor: 10.793

Review 3.  Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat.

Authors:  Scott P Commins; Maya R Jerath; Kelly Cox; Loren D Erickson; Thomas Platts-Mills
Journal:  Allergol Int       Date:  2015-11-21       Impact factor: 5.836

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.